Peringatan Keamanan

Oral LD50 in rat, mouse, and rabbit is 392 mg/kg, 439 mg/kg, and 603 mg/kg, respectively. Symptoms of overdose include drowsiness, nausea, vomiting, diarrhea, hyperventilation, tachycardia, sweating, tinnitus, disorientation, stupor, and coma. As a monotherapy, the smallest dosage capable of causing death was reported as 15 grams.

Selective COX-2 inhibitors have been associated with increased risk of serious cardiovascular events (e.g. myocardial infarction, stroke) in some patients. Current data is insufficient to assess the cardiovascular risk of diflunisal. Short-term use does not appear to be associated with increased cardiovascular risk (except when used immediately following coronary artery bypass graft (CABG) surgery). Risk of GI toxicity including bleeding, ulceration and perforation. Risk of direct renal injury, including renal papillary necrosis. Severe hepatic reactions, including cholestasis and/or jaundice, have been reported. May cause rash or hypersensitivity syndrome.

Diflunisal

DB00861

small molecule approved investigational

Deskripsi

Diflunisal, a salicylate derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with pharmacologic actions similar to other prototypical NSAIAs. Diflunisal possesses anti-inflammatory, analgesic and antipyretic activity. Though its mechanism of action has not been clearly established, most of its actions appear to be associated with inhibition of prostaglandin synthesis via the arachidonic acid pathway. Diflunisal is used to relieve pain accompanied with inflammation and in the symptomatic treatment of rheumatoid arthritis and osteoarthritis.

Struktur Molekul 2D

Berat 250.1976
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) 8 to 12 hours
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Rapidly and completely absorbed following oral administration, with a bioavailability of 80-90%. Peak plasma concentrations are achieved 2 - 3 hours following oral administration.

Metabolisme

Hepatic, primarily via glucuronide conjugation (90% of administered dose).

Rute Eliminasi

The drug is excreted in the urine as two soluble glucuronide conjugates accounting for about 90% of the administered dose. Little or no diflunisal is excreted in the feces.

Interaksi Makanan

2 Data
  • 1. Avoid alcohol.
  • 2. Take with food. Food reduces irritation.

Interaksi Obat

1543 Data
Amlodipine Diflunisal may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Diflunisal.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Diflunisal.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Diflunisal.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Diflunisal.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Diflunisal.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Diflunisal.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Diflunisal.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Diflunisal.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Diflunisal.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Diflunisal.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Diflunisal.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Diflunisal.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Diflunisal.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Diflunisal.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Diflunisal.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Diflunisal.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Diflunisal.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Diflunisal.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Diflunisal.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Diflunisal.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Diflunisal.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Diflunisal.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Diflunisal.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Diflunisal.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Diflunisal.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Diflunisal.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Diflunisal.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Diflunisal.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Diflunisal.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Diflunisal.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Diflunisal.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Diflunisal.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Diflunisal.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Diflunisal.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Diflunisal.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Diflunisal.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Diflunisal.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Diflunisal.
Benzphetamine The risk or severity of hypertension can be increased when Diflunisal is combined with Benzphetamine.
Ritodrine The risk or severity of hypertension can be increased when Diflunisal is combined with Ritodrine.
Flupentixol The risk or severity of hypertension can be increased when Diflunisal is combined with Flupentixol.
Remifentanil The risk or severity of hypertension can be increased when Diflunisal is combined with Remifentanil.
Bitolterol The risk or severity of hypertension can be increased when Diflunisal is combined with Bitolterol.
Oxymetazoline The risk or severity of hypertension can be increased when Diflunisal is combined with Oxymetazoline.
Diethylpropion The risk or severity of hypertension can be increased when Diflunisal is combined with Diethylpropion.
Salmeterol The risk or severity of hypertension can be increased when Diflunisal is combined with Salmeterol.
Naratriptan The risk or severity of hypertension can be increased when Diflunisal is combined with Naratriptan.
Frovatriptan The risk or severity of hypertension can be increased when Diflunisal is combined with Frovatriptan.
Methoxyflurane The risk or severity of hypertension can be increased when Diflunisal is combined with Methoxyflurane.
Selegiline The risk or severity of hypertension can be increased when Diflunisal is combined with Selegiline.
Ergoloid mesylate The risk or severity of hypertension can be increased when Diflunisal is combined with Ergoloid mesylate.
Isoprenaline The risk or severity of hypertension can be increased when Diflunisal is combined with Isoprenaline.
Arbutamine The risk or severity of hypertension can be increased when Diflunisal is combined with Arbutamine.
Dutasteride The risk or severity of hypertension can be increased when Diflunisal is combined with Dutasteride.
Halothane The risk or severity of hypertension can be increased when Diflunisal is combined with Halothane.
Moclobemide The risk or severity of hypertension can be increased when Diflunisal is combined with Moclobemide.
Pergolide The risk or severity of hypertension can be increased when Diflunisal is combined with Pergolide.
Desflurane The risk or severity of hypertension can be increased when Diflunisal is combined with Desflurane.
Finasteride The risk or severity of hypertension can be increased when Diflunisal is combined with Finasteride.
Aripiprazole The risk or severity of hypertension can be increased when Diflunisal is combined with Aripiprazole.
Isocarboxazid The risk or severity of hypertension can be increased when Diflunisal is combined with Isocarboxazid.
Ergometrine The risk or severity of hypertension can be increased when Diflunisal is combined with Ergometrine.
Lisdexamfetamine The risk or severity of hypertension can be increased when Diflunisal is combined with Lisdexamfetamine.
Fenoterol The risk or severity of hypertension can be increased when Diflunisal is combined with Fenoterol.
Pirbuterol The risk or severity of hypertension can be increased when Diflunisal is combined with Pirbuterol.
Ephedra sinica root The risk or severity of hypertension can be increased when Diflunisal is combined with Ephedra sinica root.
Ephedrine The risk or severity of hypertension can be increased when Diflunisal is combined with Ephedrine.
Mephentermine The risk or severity of hypertension can be increased when Diflunisal is combined with Mephentermine.
Procaterol The risk or severity of hypertension can be increased when Diflunisal is combined with Procaterol.
Yohimbine The risk or severity of hypertension can be increased when Diflunisal is combined with Yohimbine.
Methotrimeprazine The risk or severity of hypertension can be increased when Diflunisal is combined with Methotrimeprazine.
Clenbuterol The risk or severity of hypertension can be increased when Diflunisal is combined with Clenbuterol.
Bambuterol The risk or severity of hypertension can be increased when Diflunisal is combined with Bambuterol.
MMDA The risk or severity of hypertension can be increased when Diflunisal is combined with MMDA.
Midomafetamine The risk or severity of hypertension can be increased when Diflunisal is combined with Midomafetamine.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when Diflunisal is combined with 2,5-Dimethoxy-4-ethylamphetamine.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when Diflunisal is combined with 4-Methoxyamphetamine.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when Diflunisal is combined with 4-Bromo-2,5-dimethoxyamphetamine.
Tenamfetamine The risk or severity of hypertension can be increased when Diflunisal is combined with Tenamfetamine.
Chlorphentermine The risk or severity of hypertension can be increased when Diflunisal is combined with Chlorphentermine.
Dextroamphetamine The risk or severity of hypertension can be increased when Diflunisal is combined with Dextroamphetamine.
Phendimetrazine The risk or severity of hypertension can be increased when Diflunisal is combined with Phendimetrazine.
Solifenacin The risk or severity of hypertension can be increased when Diflunisal is combined with Solifenacin.
Periciazine The risk or severity of hypertension can be increased when Diflunisal is combined with Periciazine.
Acepromazine The risk or severity of hypertension can be increased when Diflunisal is combined with Acepromazine.
Thioproperazine The risk or severity of hypertension can be increased when Diflunisal is combined with Thioproperazine.
Zuclopenthixol The risk or severity of hypertension can be increased when Diflunisal is combined with Zuclopenthixol.
Epicaptopril The risk or severity of hypertension can be increased when Diflunisal is combined with Epicaptopril.
Clorgiline The risk or severity of hypertension can be increased when Diflunisal is combined with Clorgiline.
1-benzylimidazole The risk or severity of hypertension can be increased when Diflunisal is combined with 1-benzylimidazole.
Iproniazid The risk or severity of hypertension can be increased when Diflunisal is combined with Iproniazid.
Nialamide The risk or severity of hypertension can be increased when Diflunisal is combined with Nialamide.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Diflunisal is combined with Lysergic acid diethylamide.
Dronedarone The risk or severity of hypertension can be increased when Diflunisal is combined with Dronedarone.
Flibanserin The risk or severity of hypertension can be increased when Diflunisal is combined with Flibanserin.
Iloperidone The risk or severity of hypertension can be increased when Diflunisal is combined with Iloperidone.
Indacaterol The risk or severity of hypertension can be increased when Diflunisal is combined with Indacaterol.
Rotigotine The risk or severity of hypertension can be increased when Diflunisal is combined with Rotigotine.
Amibegron The risk or severity of hypertension can be increased when Diflunisal is combined with Amibegron.

Target Protein

Prostaglandin G/H synthase 2 PTGS2
Prostaglandin G/H synthase 1 PTGS1

Referensi & Sumber

Synthesis reference: Ruyle, W.V., Jarett, L.H. and Matzuk, A.R. ; U S . Patent 3,714,226; January 30, 1973; assigned to Merck & Co., Inc.

Contoh Produk & Brand

Produk: 31 • International brands: 2
Produk
  • Diflunisal
    Tablet, film coated • 500 mg/1 • Oral • US • Generic • Approved
  • Diflunisal
    Tablet, film coated • 500 mg/1 • Oral • US • Generic • Approved
  • Diflunisal
    Tablet, film coated • 500 mg/1 • Oral • US • Generic • Approved
  • Diflunisal
    Tablet, film coated • 500 mg/1 • Oral • US • Generic • Approved
  • Diflunisal
    Tablet, film coated • 500 mg/1 • Oral • US • Generic • Approved
  • Diflunisal
    Tablet, film coated • 500 mg/1 • Oral • US • Generic • Approved
  • Diflunisal
    Tablet, film coated • 500 mg/1 • Oral • US • Generic • Approved
  • Diflunisal
    Tablet • 500 mg/1 • Oral • US • Generic • Approved
Menampilkan 8 dari 31 produk.
International Brands
  • Anton — Everest
  • Dolobid — Merck

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul